Physicians’ treatment decisions, patient persistence, and interruptions in the continuous use of prostaglandin therapy in glaucoma

Author： Hahn Steven R.   Kotak Sameer   Tan Jason   Kim Elizabeth  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.26, Iss.4, 2010-04, pp. : 957-963

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Persistence with Prostaglandin Agonist Use with and without Adjunctive Therapy for Glaucoma Patients: A Canadian Population-Based Analysis

By Iskedjian Michael  

The Patient: Patient-Centered Outcomes Research, Vol. 4, Iss. 2, 2011-06 ,pp. : 133-141

Adis International

Access to resources Recommend Favorite

Blepharoptosis onset after topical prostaglandin therapy for glaucoma

By  

CLINICAL & EXPERIMENTAL OPHTHALMOLOGY, Vol. 1442-6404, Iss. 7, 2015-09 ,pp. : 689-690

John Wiley & Sons Inc

Access to resources Recommend Favorite

Blepharoptosis onset after topical prostaglandin therapy for glaucoma

By  

CLINICAL & EXPERIMENTAL OPHTHALMOLOGY, Vol. 43, Iss. 7, 2015-09 ,pp. : 689-690

John Wiley & Sons Inc

Access to resources Recommend Favorite

Continuous Renal Replacement Therapy in Successful Treatment of a Patient With Hyperlipidemic Acute Pancreatitis

By  

THERAPEUTIC APHERESIS AND DIALYSIS, Vol. 19, Iss. 5, 2015-10 ,pp. : 518-521

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of a multi-biomarker disease activity test on rheumatoid arthritis treatment decisions and therapy use

By Li Wanying   Sasso Eric H.   Emerling Daniel   Cavet Guy   Ford Kerri  

Current Medical Research and Opinion, Vol. 29, Iss. 1, 2013-01 ,pp. : 85-92

Informa Healthcare

Access to resources Recommend Favorite